| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Medicine [M. S. D., B. B., G. G.], Clinical Immunology, Microbiology, Pathology, and Infection [M. R. A., C. I. E. S., B. C.], Gene Therapy Research Center, Clinical Research Center [C. I. E. S.], Huddinge Hospital, Karolinska Institute, S-14186 Huddinge, Sweden; Center for BioTechnology, the Department of Biosciences [M. S. D., C. I. E. S.], Karolinska Institute, NOVUM, S-14157 Huddinge, Sweden; and Departments of Physiology [G. M. K.] and Anatomy and Cell Biology [C. C. G. N.], The University of Western Ontario, London, Ontario, N6A 5C1 Canada
Transfer of the herpes simplex thymidine kinase gene (HSVtk) into tumor cells followed by the administration of ganciclovir (GCV) provides a potential strategy for the treatment of some malignancies. During GCV treatment, not only the cells that express the HSVtk gene are killed but also frequently neighboring tumor cells that are not genetically altered. This has been called the "bystander effect." Although the mechanism of the bystander effect in vivo remains elusive, our results suggest that gap junction formation between neighboring cells is an important contributing factor.
The C6 rat glioma cell line, which exhibits a low level of intercellular communication by gap junctions and connexin43 (Cx43)-transfected clones of this cell line forming gap junctions from a moderate level (Cx43-12 and Cx43-14) to a high level (Cx43-13), were transduced with HSVtk. Transduced and nontransduced cells were mixed in various concentrations and then cultured in vitro or injected s.c. into C.B-17/SCID-beige mice followed by i.p. injections of GCV. Cx43-transfected clones showed a significant increase of the bystander effect compared with the less coupled C6 parental cell line. In 11 of 12 mice injected with cells of Cx43-transfected clones, no tumors were seen at the inoculation site when a mixture of 50% HSVtk-negative and HSVtk-positive cells was used. Moreover, in mice injected with cells of clone Cx43-13, which exhibits the highest intercellular communication, tumors were frequently undetectable at the inoculation site when using mixtures of 75% HSVtk-negative and 25% HSVtk-positive cells, and even mixtures containing 5% HSVtk-positive cells of Cx43-transfected clones showed tumor size reduction. All animals in control groups (n = 26) developed large tumors at every injection site. These results demonstrate that gap junctions are an important component in mediating the bystander effect in vivo.
1 This study was supported by grants from the Swedish Medical Research Council, the Swedish Cancer Society, the BIOMED Shared Cost Grant BMH4-CT96-1436, and the Cancer Research Society, Inc.
2 To whom requests for reprints should be addressed, at Karolinska Institute, Hematology Laboratory, KFC, NOVUM, S-14186, Huddinge, Sweden. Phone: 46 8 7465066; Fax: 46 8 7465210; E-mail: Sirac.Dilber@medhs.ki.se.
Received 10/23/96. Accepted 2/17/97.
This article has been cited by other articles:
![]() |
J.-C. Tseng, P. B. Zanzonico, B. Levin, R. Finn, S. M. Larson, and D. Meruelo Tumor-Specific In Vivo Transfection with HSV-1 Thymidine Kinase Gene Using a Sindbis Viral Vector as a Basis for Prodrug Ganciclovir Activation and PET J. Nucl. Med., July 1, 2006; 47(7): 1136 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Gentry, P. D. Boucher, and D. S. Shewach Hydroxyurea Induces Bystander Cytotoxicity in Cocultures of Herpes Simplex Virus Thymidine Kinase-Expressing and Nonexpressing HeLa Cells Incubated with Ganciclovir. Cancer Res., April 1, 2006; 66(7): 3845 - 3851. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Mahan, G. C. Ireton, C. Knoeber, B. L. Stoddard, and M. E. Black Random mutagenesis and selection of Escherichia coli cytosine deaminase for cancer gene therapy Protein Eng. Des. Sel., August 1, 2004; 17(8): 625 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qiu, J. S. Harms, J. Zhu, and G. A. Splitter Bovine Herpesvirus Tegument Protein VP22 Enhances Thymidine Kinase/Ganciclovir Suicide Gene Therapy for Neuroblastomas Compared to Herpes Simplex Virus VP22 J. Virol., April 15, 2004; 78(8): 4224 - 4233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Thust, M.T. Tomicic, R. Grabner, C. Friedrichs, P. Wutzler, and B. Kaina Cytogenetic detection of a trans-species bystander effect: induction of sister chromatid exchanges in murine 3T3 cells by ganciclovir metabolized in HSV thymidine kinase gene-transfected Chinese hamster ovary cells Mutagenesis, January 1, 2004; 19(1): 27 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. K. Gadi, S. D. Alexander, W. R. Waud, P. W. Allan, W. B. Parker, and E. J. Sorscher A Long-Acting Suicide Gene Toxin, 6-Methylpurine, Inhibits Slow Growing Tumors after a Single Administration J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1280 - 1284. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Kokoris and M. E. Black Characterization of Herpes Simplex Virus type 1 thymidine kinase mutants engineered for improved ganciclovir or acyclovir activity Protein Sci., September 1, 2002; 11(9): 2267 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muramatsu, M. Iwai, T. Morikawa, S. Tanaka, T. Mori, Y. Harada, and T. Okanoue Influence of transfection with connexin 26 gene on malignant potential of human hepatoma cells Carcinogenesis, February 1, 2002; 23(2): 351 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Burton, J. B. Wechuck, S. K. Wendell, W. F. Goins, D. J. Fink, and J. C. Glorioso Multiple Applications For Replication-Defective Herpes Simplex Virus Vectors Stem Cells, September 1, 2001; 19(5): 358 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zheng, M. Johansson, and A. Karlsson Bystander Effects of Cancer Cell Lines Transduced with the Multisubstrate Deoxyribonucleoside Kinase of Drosophila melanogaster and Synergistic Enhancement by Hydroxyurea Mol. Pharmacol., August 1, 2001; 60(2): 262 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Y.P. Lam and X. O. Breakefield Potential of gene therapy for brain tumors Hum. Mol. Genet., April 1, 2001; 10(7): 777 - 787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mesnil and H. Yamasaki Bystander Effect in Herpes Simplex Virus-Thymidine Kinase/Ganciclovir Cancer Gene Therapy: Role of Gap-junctional Intercellular Communication1 Cancer Res., August 1, 2000; 60(15): 3989 - 3999. [Abstract] [Full Text] |
||||
![]() |
R. Thust, M. Tomicic, R. Klocking, P. Wutzler, and B. Kaina Cytogenetic genotoxicity of anti-herpes purine nucleoside analogues in CHO cells expressing the thymidine kinase gene of herpes simplex virus type 1: comparison of ganciclovir, penciclovir and aciclovir Mutagenesis, March 1, 2000; 15(2): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Murray, K. Davis, L. M. Fishman, and S. R. Bornstein {alpha}1 Connexin 43 Gap Junctions Are Decreased in Human Adrenocortical Tumors J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 890 - 895. [Abstract] [Full Text] |
||||
![]() |
F. Princen, P. Robe, C. Lechanteur, M. Mesnil, J.-M. Rigo, J. Gielen, M.-P. Merville, and V. Bours A Cell Type-specific and Gap Junction-independent Mechanism for the Herpes Simplex Virus-1 Thymidine Kinase Gene/Ganciclovir-mediated Bystander Effect Clin. Cancer Res., November 1, 1999; 5(11): 3639 - 3644. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. W. Laird, P. Fistouris, G. Batist, L. Alpert, H. T. Huynh, G. D. Carystinos, and M. A. Alaoui-Jamali Deficiency of Connexin43 Gap Junctions Is an Independent Marker for Breast Tumors Cancer Res., August 1, 1999; 59(16): 4104 - 4110. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhang, W. T. Couldwell, M. F. Simard, H. Song, J. H-C. Lin, and M. Nedergaard Direct Gap Junction Communication between Malignant Glioma Cells and Astrocytes Cancer Res., April 1, 1999; 59(8): 1994 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Z. Rubsam, P. D. Boucher, P. J. Murphy, M. KuKuruga, and D. S. Shewach Cytotoxicity and Accumulation of Ganciclovir Triphosphate in Bystander Cells Cocultured with Herpes Simplex Virus Type 1 Thymidine Kinase-expressing Human Glioblastoma Cells Cancer Res., February 1, 1999; 59(3): 669 - 675. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Carystinos, M. M. Katabi, D. W. Laird, J. Galipeau, H. Chan, M. A. Alaoui-Jamali, and G. Batist Cyclic-AMP Induction of Gap Junctional Intercellular Communication Increases Bystander Effect in Suicide Gene Therapy Clin. Cancer Res., January 1, 1999; 5(1): 61 - 68. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |